DEXCOM, INC.

(DXCM)
  Report
Delayed Nasdaq  -  05/20 04:00:01 pm EDT
321.23 USD   +1.62%
09:04aDEXCOM INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/17Citigroup Adjusts DexCom's Price Target to $525 From $630, Reiterates Buy Rating
MT
05/11TRANSCRIPT : DexCom, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-2022 02:40 PM
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on DEXCOM, INC.
05/17Citigroup Adjusts DexCom's Price Target to $525 From $630, Reiterates Buy Rating
MT
04/29Raymond James Adjusts DexCom's Price Target to $486 From $538, Keeps Outperform Rating
MT
04/29Morgan Stanley Adjusts Price Target for DexCom to $492 From $514, Maintains Equalweigh..
MT
04/29SVB Leerink Adjusts DexCom's Price Target to $500 From $565, Keeps Outperform Rating
MT
04/29Piper Sandler Adjusts DexCom's Price Target to $480 From $725, Reiterates Overweight Ra..
MT
03/02BofA Securities Reinstates DexCom at Buy With $500 Price Target
MT
02/11Morgan Stanley Cuts Price Target on DexCom to $514 From $570, Maintains Equalweight Rat..
MT
02/03BTIG Upgrades DexCom to Buy from Neutral, Sets $535 Price Target
MT
01/31Oppenheimer Adjusts DexCom's Price Target to $580 From $630, Maintains Outperform Ratin..
MT
01/19Raymond James Adjusts DexCom's Price Target to $538 from $618, Keeps Outperform Rating
MT
01/19Wells Fargo Upgrades DexCom to Overweight From Equalweight; Price Target is $575
MT
01/11UBS Adjusts DexCom Price Target to $640 From $660, Maintains Buy Rating
MT
01/07Morgan Stanley Lowers DexCom's Price Target to $570 From $576, Maintains Equalweight Ra..
MT
01/07Guggenheim Upgrades DexCom to Buy from Neutral, Sets $580 Price Target
MT
2021Berenberg Bank Terminates Coverage on a Number of Companies Due to Analysts' Departures..
MT
2021Oppenheimer Adjusts DexCom PT to $630 From $625, Maintains Outperform Rating
MT
2021Piper Sandler Adjusts DexCom's Price Target to $750 From $675, Reiterates Overweight Ra..
MT
2021Raymond James Adjusts DexCom's Price Target to $618 from $515, Keeps Outperform Rating
MT
2021Oppenheimer Adjusts DexCom PT to $625 From $525, Maintains Outperform Rating
MT
2021Baird Adjusts DexCom's Price Target to $625 From $520, Reiterates Outperform Rating
MT
2021SVB Leerink Adjusts DexCom's Price Target to $715 from $500, Keeps Outperform Rating
MT
2021UBS Raises DexCom's Price Target to $660 From $610, Reiterates Buy Rating
MT
2021Piper Sandler Adjusts DexCom's Price Target to $675 From $650, Reiterates Overweight Ra..
MT
2021Jefferies Adjusts DexCom's Price Target to $655 From $610, Reiterates Buy Rating
MT
2021Wells Fargo Adjusts DexCom PT to $575 From $475, Maintains Equal Weight Rating
MT
2021Raymond James Adjusts DexCom PT to $618 From $515, Maintains Outperform Rating
MT
2021JPMorgan Adjusts DexCom PT to $600 From $500, Maintains Overweight Rating
MT
2021Canaccord Genuity Adjusts DexCom PT to $625 From $500, Maintains Buy Rating
MT
2021Morgan Stanley Adjusts Price Target on DexCom to $576 From $510, Maintains Equal-Weight..
MT
2021Berenberg Bank Adjusts DexCom PT to $630 From $550 Following Q3 Beat, Maintains Buy Rat..
MT
2021DEXCOM : Guggenheim Downgrades DexCom to Neutral from Buy
MT
2021DEXCOM : Piper Sandler Raises Price Target on DexCom to $650 From $550, Maintains Overweig..
MT
2021DEXCOM : Morgan Stanley Adjusts DexCom's Price Target to $510 from $410, Keeps Equalweight..
MT
2021DEXCOM : Oppenheimer Adjusts DexCom PT to $525 From $500 on Q2 Beat & Raised Guidance, Mai..
MT
2021DEXCOM : Raymond James Adjusts DexCom's Price Target to $515 From $466, Keeps Outperform R..
MT
2021DEXCOM : Canaccord Genuity Adjusts DexCom's Price Target to $500 From $455, Reiterates Buy..
MT
2021DEXCOM : UBS Adjusts DexCom's Price Target to $525 From $500, Maintains Buy Rating
MT
2021DEXCOM : JPMorgan Adjusts DexCom's Price Target to $500 From $450, Maintains Overweight Ra..
MT
2021DEXCOM : Baird Adjusts DexCom's Price Target to $520 From $460, Keeps Outperform Rating
MT
2021DEXCOM : SVB Leerink Adjusts Price Target on DexCom to $500 From $485, Maintains Outperfor..
MT
2021DEXCOM : Piper Sandler Adjusts DexCom's Price Target to $550 From $500, Reiterates Overwei..
MT
2021DEXCOM : Wells Fargo Adjusts DexCom's Price Target to $475 From $380, Keeps Equal-Weight R..
MT
2021DEXCOM : Berenberg Bank Adjusts DexCom's Price Target to $550 From $497 Following Q2 Beat,..
MT
2021DEXCOM : Cowen Analyst Assumes Coverage on Outperform-Rated DexCom, Sets $525 Price Target
MT
2021DEXCOM : Oppenheimer Adjusts DexCom PT to $500 From $480, Maintains Outperform Rating
MT
2021DEXCOM : Wells Fargo Upgrades DexCom to Equal-Weight From Underweight; Price Target is $38..
MT
2021DEXCOM : Barclays Initiates Coverage on DexCom With Overweight Rating, $500 Price Target
MT
2021DEXCOM : Oppenheimer Adjusts DexCom PT to $480 From $450 on Q1 Beat and Raised Guidance, M..
MT
2021DEXCOM : Raymond James Adjusts Price Target on DexCom to $466 From $449, Maintains Outperf..
MT
2021DEXCOM : UBS Adjusts DexCom's Price Target to $500 From $475, Citing Higher 2022 Sales Est..
MT
2021DEXCOM : Citigroup Adjusts DexCom's Price Target to $488 From $480, Maintains Buy Rating
MT
2021DEXCOM : Atlantic Equities Starts DexCom at Overweight With $438 Price Target
MT
2021DEXCOM : Oppenheimer Adjusts DexCom PT to $450 From $445, Maintains Outperform Rating
MT
2021DEXCOM : UBS Adjusts DexCom's Price Target to $475 From $445, Maintains Buy Rating
MT
2021DEXCOM : Morgan Stanley Adjusts Price Target on DexCom to $410 From $402, Maintains Equal-..
MT
2021DEXCOM : UBS Raises DexCom to Buy From Neutral, PT to $445 From $410, Citing Pharmacy Shif..
MT
2020DEXCOM : Morgan Stanley Adjusts DexCom PT to $402 From $398, Maintains Equal Weight Rating
MT
2020DEXCOM : Canaccord Genuity Adjusts DexCom's Price Target to $435 From $475, Maintains Buy ..
MT
Upcoming event on DEXCOM, INC.